Shopping Cart
Remove All
Your shopping cart is currently empty
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $290 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $755 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,200 | 2-4 weeks | 2-4 weeks |
| Description | Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies. |
| In vitro | Cevostamab exhibits potent, dose-dependent killing effects on B cells and bone marrow plasma cells in peripheral blood mononuclear cell (PBMC)/bone marrow monocyte cell (BMMC) samples from rhesus monkeys [1]. |
| In vivo | Cevostamab (0.5 mg/kg; intravenous; weekly) inhibited growth of MOLP-2 tumors in mice reconstituted with human immune cells. |
| Synonyms | RO7187797, RO 7187797, RG6160, RG 6160, BFCR4350A, BFCR 4350A |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CD3 |
| Cas No. | 2249888-53-5 |
| Isotype | IgG1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.